medline.ch Respirationstrakt Neoplasie

	Feasibility and preliminary efficacy of an art-making program to manage fear of cancer recurrence (AM-I-FCR) in lung cancer patients: a randomized controlled pilot study. BMC Med Lin J, Kang Z, Zhang C, Arbing R, Chen WT, Huang F. PMID: 41761252 [PubMed - as supplied by publisher]
	Efficacy and tolerability of first-line treatment regimens for extensive-stage small cell lung cancer - a grade-assessed network meta-analysis of randomized controlled trials. BMC Cancer Najah Q, Makhlouf HA, Osman ASA, Almosilhy NA, Abusalah MA, Abuhlaiga MA, Qutob IA, Abdelgawad HAH. PMID: 41761164 [PubMed - as supplied by publisher]
	SLC and ABC Transporters in Lung Cancer: Orchestrators of Malignancy and Therapeutic Resistance. Compr Physiol Li P, Dong M, Chen B, Luo J, Jiang H, Lin N. PMID: 41761042 [PubMed - in process]
	Efficacy and safety of tepotinib in METâ€‘altered nonâ€‘small cell lung cancer: a meta-analysis. Sci Rep Xiao J, Cai Q, Li X, Zhang D. PMID: 41760894 [PubMed - as supplied by publisher]
	Characterizing Risk Factors and Outcomes in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer Who Do Not Complete, or Who Experience Progression During/Within 42 Days of, Concurrent Chemoradiotherapy: The POSITION Study. Clin Lung Cancer Mountzios G, Weng JK, Zairi E, Hsieh K, Chander P, Dunlop W, Qiao Y, Wang A, Januszewski A. PMID: 41760536 [PubMed - as supplied by publisher]
	ScRNA-Seq: A way to reveal the potential mechanisms of metastasis in small cell lung cancer. Bull Cancer Guan XL, Gan DX, Wu Y, Zhang Y. PMID: 41760455 [PubMed - as supplied by publisher]
	History of Chronic Obstructive Pulmonary Disease May Contribute to Earlier Diagnosis of Lung Cancer. In Vivo Marel M, Domecky P, Fernando CML, Bejckova A, Fila L, Hrnciarik M, Vencalek T, Roubec J, Duba J, Svaton M. PMID: 41760320 [PubMed - in process]
	Mechanistic Studies of Anticancer Effects of Salicylaldehyde Benzoylhydrazone in 2D/3D Lung Cancer Cell Cultures. Anticancer Res Sangseekew W, Boonsombat J, Thongnest S, Sirirak J, Sornprachum T, Lirdprapamongkol K, Svasti J, Ruchirawat S, Keeratichamroen S. PMID: 41760238 [PubMed - in process]
	Cost Evaluation of a Multimodal Prehabilitation Program for High-risk Lung Cancer Surgery. J Thorac Cardiovasc Surg Ghezeljeh TN, Cho AR, Guigui A, Douglas L, Schwartzman K, Ramanakumar AV, Tsang J, Ferri L, Cools-Lartigue J, Spicer JD, Najmeh S, Carli F. PMID: 41759946 [PubMed - as supplied by publisher]
	Exosome-mediated crosstalk between immune cells and tumor microenvironment in lung cancer: Implications for immune evasion and therapeutic resistance. Cell Signal Tang R, Juan Z, Xing F, Yi Z, Fu Y. PMID: 41759799 [PubMed - as supplied by publisher]
	The effect of frailty on early postoperative outcomes of lobectomy for lung cancer in older adults - A United States National Retrospective Cohort Study. J Geriatr Oncol Barragan-Bradford D, Oganesyan R, Nagrebetsky A, Hyder O. PMID: 41759405 [PubMed - as supplied by publisher]
	Long-term exposure to air pollution and 5-year mortality after lung cancer diagnosis: a Danish nurse cohort study. Environ Int Effing SM, Zhang J, Tuffier S, Cole-Hunter T, Bergmann M, Napolitano GM, So R, Brandt J, Ketzel M, Loft S, Hart JE, Lim YH, Andersen ZJ. PMID: 41759279 [PubMed - as supplied by publisher]
	TIGOS Trial: A Randomized, Double-Blind, Phase III Trial of Atigotatug and Nivolumab Fixed-Dose Combination With Chemotherapy Versus Atezolizumab With Chemotherapy as First-Line Therapy in Patients With Extensive-Stage Small Cell Lung Cancer. Clin Lung Cancer Paz-Ares LG, O'Byrne KJ, Johnson ML, Reck M, Girard N, Hayashi H, Zhou C, Gharpure VS, Pisupati R, Pacius M, Ready NE. PMID: 41759251 [PubMed - as supplied by publisher]
	Surgical outcomes of left atrial resection for lung cancer: A single-center study. Turk Gogus Kalp Damar Cerrahisi Derg Kosif A, Ersöz Köse E, A, Ç, Evman RS, Alpay AL, Baysungur V. PMID: 41757477 [PubMed - as supplied by publisher]
	Extended Anticoagulation Therapy With Rivaroxaban for Cancer-Associated Low-Risk Pulmonary Embolism According to Different Performance Status Scores: Insights From the ONCO PE Randomized Trial. J Am Heart Assoc Xiong W, Yamashita Y, Morimoto T, Muraoka N, Shioyama W, Nakagawa Y, Chatani R, Yamamoto H, Shibata T, Morikawa N, Fukumoto Y, Nishimoto Y, Ono K, Kimura T, ONCO PE Trial Investigators. PMID: 41757461 [PubMed - as supplied by publisher]
	Risk factors for atrial fibrillation after lung cancer surgery: a meta-analysis. Front Cardiovasc Med Zhang J, Liu S, Li J, Wang Y, Ni M, Jiang C, Huang S, Guo Z. PMID: 41756510 [PubMed]
	Correction: TROPION-Lung10: a phase 3 study of datopotamab deruxtecan and rilvegostomig in patients with treatment-naÃ¯ve locally advanced or metastatic nonsquamous non-small cell lung cancer with high PD-L1 expression and without actionable genomic alterations. Front Oncol Frontiers Production Office. PMID: 41756332 [PubMed]
	Lung adenocarcinoma with KRAS-Q61H: clinicopathologic features, diagnostics, and the evolving treatment landscape. Front Oncol Serafimidis I. PMID: 41756324 [PubMed]
	Evaluation of the Dose Distribution Robustness for Lung Tumor Tracking in Robotic Radiotherapy Using Four-Dimensional Computed Tomography. Cureus Miyabe Y, Yamanaka H, Seki H, Iwata H, Mizoe J. PMID: 41755961 [PubMed]
	Rationale for the Nodule Management Protocol of the Australian National Lung Cancer Screening Program. J Med Imaging Radiat Oncol McCusker MW, Ellis S, Pascoe DM, Jones CM, Melsom S, McWilliams A, Leong TL, Marshall H, Fong KM, Brims FJH, Siemienowicz M. PMID: 41755713 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 157571

Seite 1 von 7879



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung